Physician profile
Alicia R Lai
NPI 1023372653
$5,044.87
in general payments reported to CMS, 2019-2025
30 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 89% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $352 · 2021: $902 · 2022: $855 · 2023: $668 · 2024: $343 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,223 · Long Term Medical Supply Or Device Loan: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,222.50 |
| Long Term Medical Supply Or Device Loan | $1,123.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,241.99 | 2023-2025 | Amnioexcel Plus, Integra, Integra Dermal Regeneration Template |
| Abbott Laboratories | $375.73 | 2019-2021 | |
| Smith+Nephew, INC. | $363.96 | 2021-2025 | Collagenase Santyl, Grafix Pl |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $307.85 | 2019-2022 | |
| Grt US Holding, INC. | $263.58 | 2021-2022 | |
| Stryker Corporation | $254.25 | 2019-2021 | |
| Paragon 28, INC. | $253.01 | 2021-2023 | |
| Treace Medical Concepts, INC. | $174.12 | 2024-2025 | |
| Organogenesis INC. | $166.49 | 2022-2025 | Puraply Wound Matrix, Via Matrix |
| Paratek Pharmaceuticals, INC. | $137.06 | 2021-2025 | Nuzyra |
| Progenacare Global, LLC | $136.62 | 2023 | |
| Kerecis Limited | $129.77 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Allergan, INC. | $124.82 | 2019 | |
| Wright Medical Technology, INC. | $117.94 | 2019 | |
| Horizon Therapeutics Plc | $116.06 | 2023 | Krystexxa |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $115.74 | 2020 | |
| Averitas Pharma INC. | $115.59 | 2023-2024 | Qutenza |
| Abbvie INC. | $113.88 | 2022 | |
| Bard Peripheral Vascular, INC. | $113.72 | 2020 | |
| Nevro Corp. | $104.16 | 2023 | Senza |
| Trilliant Surgical LLC. | $60.70 | 2021 | |
| Amgen INC. | $60.21 | 2024-2025 | Krystexxa |
| Reprise Biomedical, INC. | $46.84 | 2025 | Miro 3d, Miro3d |
| Next Science LLC | $46.67 | 2022 | |
| Convatec INC. | $23.79 | 2025 | |
| Depuy Synthes Sales INC. | $21.74 | 2022 | |
| Bioventus LLC | $21.09 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.07 | 2023 | Seglentis |
| Advanced Oxygen Therapy INC. | $13.00 | 2025 | Topical Oxygen Chamber For Extremities |
| Cashflow Solutions, LLC | $9.42 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicia Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.